Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline describes novel integrin antagonists

Oct. 13, 2017

Merck & Co. discloses CHRNA7 PAMs

Oct. 11, 2017

Afferent Pharmaceuticals identifies P2X2/3 receptor antagonists

Oct. 11, 2017

Merck & Co. divulges novel Nav1.7 channel blockers

Oct. 11, 2017

DUB inhibitors presented by Mission Therapeutics

Oct. 11, 2017

Bristol-Myers Squibb presents compounds for treating HCV infections

Oct. 11, 2017

Novel Ret inhibitors presented by Blueprint Medicines

Oct. 10, 2017

DGMIF and Gachon University patent FGFR inhibitors

Oct. 10, 2017

Centaurus BioPharma and collaborators divulge novel CDK inhibitors

Oct. 10, 2017

New integrin antagonists presented by GlaxoSmithKline

Oct. 10, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...